The short answer
If you’re under 60 and within about 10 years of your last period, estradiol is the most effective treatment for hot flashes — nothing non-hormonal matches it. Everything else on this page is either a fallback for when estrogen isn’t appropriate or something you stack on top.
That ranking isn’t a preference. It falls out of what a hot flash actually is.
One flush, two opposite fixes
A hot flash starts in the hypothalamus, in the thermoregulatory center that decides when you’re too warm. Estrogen keeps that center’s comfortable temperature band wide. As estrogen falls in menopause the band narrows to almost nothing — a fraction of a degree of internal warming now trips the full heat-dumping response: flush, sweat, chill. Upstream, a cluster of hypothalamic KNDy neurons loses its estrogen brake and fires harder, signaling through neurokinin B onto the NK3 receptor.
That single mechanism explains why two drugs that look like opposites both work. Estradiol restores the estrogen signal and re-widens the band. Fezolinetant ignores estrogen entirely and blocks the NK3 receptor downstream. Same circuit, two entry points.
The options, ranked
Estradiol (oral or transdermal patch) — first line. It reduces hot-flash frequency and severity more than any non-hormonal option. If you have an intact uterus you add progesterone to protect the endometrium — that part is not optional. The patch is generally preferred over oral because it skips first-pass liver metabolism and carries a lower venous-clot signal, which is the standard reason to start transdermal in anyone with clot risk.
Fezolinetant (Veozah) — first-line non-hormonal. FDA-approved in 2023 for moderate-to-severe hot flashes. It exists precisely for women who can’t or won’t take estrogen — hormone-sensitive cancer history, clotting history, personal choice. Newer and more expensive, and it requires baseline and periodic liver monitoring — a real barrier if you already have liver disease.
Paroxetine 7.5 mg (Brisdelle) — the non-hormonal fallback with a label. The only SSRI FDA-approved for hot flashes. Partial effect, not a full one. Reasonable when HRT is off the table and you’d rather not start fezolinetant.
Gabapentin — nighttime-specific. Its sedation is the point: dosed at bedtime it blunts the night sweats that wreck sleep. Its mechanism for hot flashes specifically is not well established, so use it for that pattern, not as a general first choice.
What actually stacks on top
Behavioral changes don’t replace the drugs, but they’re free and they compound:
- Identify and cut personal triggers — alcohol, caffeine, spicy food, hot rooms. A two-week trigger journal beats guessing.
- Layer natural-fiber clothing you can shed; keep the bedroom cold.
- Cooling pillow, about $30, no drug interaction.
None of this touches the hypothalamic setpoint. It lowers how often you cross it.
What isn’t worth your money
Black cohosh, evening primrose oil, and most “menopause support” supplements. The trial evidence is weak or null, and we don’t sell them for that reason. They’re not dangerous — they’re just not doing what the label implies. If a supplement worked as well as estradiol, it would be a drug.
What’s still unsettled
The open question isn’t whether estrogen works — it’s duration. How long to stay on it, and exactly when the benefit-risk balance turns for a given woman, is still individualized rather than settled by one clean trial. That’s a conversation for your annual review, not a number you can look up.
Takeaways
- Evidence and guideline consensus: Estradiol is the most effective treatment for hot flashes; fezolinetant is the leading non-hormonal option.
- Guideline consensus: Most women under 60 and within 10 years of menopause onset are HRT candidates. An intact uterus means adding progesterone.
- Our clinical position: Start with the patch when clot risk is a factor, treat the supplement aisle as inert, and stack behavioral changes on whatever drug you choose.
Not sure which bucket you’re in? Start with the quiz.
